The current therapeutic options for Crohn’s disease: from medical therapy to intestinal transplantation

References

• Freeman HJ. Natural history and long-term clinical course of Crohn’s disease. World J Gastroenterol. 2014;20:31–36.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, et al. Surgery in a population-based cohort of Crohn’s disease from Olmsted county, Minnesota (1970-2004). Am J Gastroenterol. 2012;107:1693–1701.
   PubMed Web of Science ®Google Scholar
• Fornaro R, Caratto E, Caratto M, et al. Post-operative recurrence in Crohn’s disease. Critical analysis of potential risk factors. An update. Surgeon. 2015;13:330–347.
   PubMed Web of Science ®Google Scholar
• Limketkai BN, Orandi B, Luo X, et al. Intestinal transplantation for Crohn’s disease: a 5-year nationwide follow-up. Gastroenterology. 2015;148:S241.
   Web of Science ®Google Scholar
• Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34:171–180.
   PubMed Web of Science ®Google Scholar
• Limketkai BN, Parian AM, Shah ND, et al. Short bowel syndrome and intestinal failure in Crohn’s disease. Inflamm Bowel Dis. 2016;22:1209–1218.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.
   PubMed Web of Science ®Google Scholar
• Calvert CR, Lal S. Approaches to intestinal failure in Crohn’s disease. Proc Nutr Soc. 2011;70:336–341.
   PubMed Web of Science ®Google Scholar
• Harrison E, Allan P, Ramu A, et al. Management of intestinal failure in inflammatory bowel disease: small intestinal transplantation or home parenteral nutrition? World J Gastroenterol. 2014;20:3153–3163.
   PubMed Web of Science ®Google Scholar
• Smith T, Micklewright A, Stratton R, et al. British association of parenteral and enteral nutrition BANS report, 2011: artificial nutrition support in the UK 2000-2010. Annu BANS Rep. 2011;10:1–50.
   Google Scholar
• Stappenbeck TS, McGovern DP. Paneth cell alterations in the development and phenotype of Crohn’s disease. Gastroenterology. 2017;152:322–326.
   PubMed Web of Science ®Google Scholar
• Roggenbuck D, Reinhold D, Baumgart DC, et al. Autoimmunity in Crohn’s disease – a putative stratification factor of the clinical phenotype. Adv Clin Chem. 2016;77:77–101.
   PubMed Web of Science ®Google Scholar
• Lee SD, Rubin DT, Sandborn WJ, et al. Reinduction with certolizumab pegol in patients with Crohn’s disease experiencing disease exacerbation: 7-year data from the PRECiSE 4 study. Inflamm Bowel Dis. 2016;22:1870–1880.
   PubMed Web of Science ®Google Scholar
• Duran NE, Hommes DW. Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls. Ther Adv Gastroenterol. 2016;9:533–547.
   PubMed Web of Science ®Google Scholar
• Al Nabhani Z, Lepage P, Mauny P, et al. Nod2 deficiency leads to a specific and transmissible mucosa-associated microbial dysbiosis which is independent of the mucosal barrier defect. J Crohns Colitis. 2016;10:1428–1436.
   PubMed Web of Science ®Google Scholar
• Duricova D, Fumery M, Annese V, et al. The natural history of Crohn’s disease in children: a review of population-based studies. Eur J Gastroenterol Hepatol. 2017;29:125–134.
   PubMed Web of Science ®Google Scholar
• Duricova D, Burisch J, Jess T, et al. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis. 2014;8:1351–1361.
   PubMed Web of Science ®Google Scholar
• Gomollón F, Dignass A, Annese V, et al. EUROPEAN evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11:3–25.
   PubMed Web of Science ®Google Scholar
• Elriz K, Palascak-Juif V, Joly F, et al. Crohn’s disease patients with chronic intestinal failure receiving long-term parenteral nutrition: a cross-national adult study. Aliment Pharmacol Ther. 2011;34:931–940.
   PubMed Web of Science ®Google Scholar
• Uchino M, Ikeuchi H, Bando T, et al. Risk factors for short bowel syndrome in patients with Crohn’s disease. Surg Today. 2012;42:447–452.
   PubMed Web of Science ®Google Scholar
• Dias CC, Rodrigues PP, Da Costa-Pereira A, et al. Clinical prognostic factors for disabling Crohn’s disease: a systematic review and meta-analysis. World J Gastroenterol. 2013;19:3866–3871.
   PubMed Web of Science ®Google Scholar
• Gearry RB, Kamm MA, Hart AL, et al. Predictors for developing intestinal failure in patients with Crohn’s disease. J Gastroenterol Hepatol. 2013;28:801–807.
   PubMed Web of Science ®Google Scholar
• Severs M, Van Erp SJ, Van Der Valk ME, et al. Smoking is associated with extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:455–461.
   PubMed Web of Science ®Google Scholar
• Huang W, Tang Y, Nong L, et al. Risk factors for postoperative intraabdominal septic complications after surgery in Crohn’s disease: a metaanalysis of observational studies. J Crohns Colitis. 2015;9:293–301.
   PubMed Web of Science ®Google Scholar
• Datta V, Engledow A, Chan S, et al. The management of enterocutaneous fistula in a regional unit in the United Kingdom: a prospective study. Dis Colon Rectum. 2010;53:192–199.
   PubMed Web of Science ®Google Scholar
• Cleynen I, González JR, Figueroa C, et al. Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBDchip European Project. Gut. 2013;62:1556–1565.
   PubMed Web of Science ®Google Scholar
• Grossi V, Hyams JS. The safety of treatment options for pediatric Crohn’s disease. Expert Opin Drug Saf. 2016;15:1383–1390.
   PubMed Web of Science ®Google Scholar
• Cottone M, Renna S, Orlando A, et al. Medical management of Crohn’s disease. Expert Opin Pharmacother. 2011;12:2505–2525.
   PubMed Web of Science ®Google Scholar
• Lim WC, Hanauer S. Aminosalicylates for induction of remission or response in Crohn’s disease. Cochrane Database Syst Rev. 2010;12:CD008870.
   PubMed Web of Science ®Google Scholar
• Akobeng AK, Zhang D, Gordon M, et al. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn’s disease. Cochrane Database Syst Rev. 2016 Sep 28;9:CD003715. [ Epub ahead of print].
   Web of Science ®Google Scholar
• Nakase H, Yoshino T, Matsuura M. Role in calcineurin inhibitors for inflammatory bowel disease in the biologics era: when and how to use. Inflamm Bowel Dis. 2014;20:2151–2156.
   PubMed Web of Science ®Google Scholar
• McDonald JW, Feagan BG, Jewell D, et al. Cyclosporine for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000297.
   Web of Science ®Google Scholar
• Gabbani T, Deiana S, Lunardi S, et al. Safety profile of methotrexate in inflammatory bowel disease. Expert Opin Drug Saf. 2016;15:1427–1437.
   PubMed Web of Science ®Google Scholar
• Simon M, Pariente B, Lambert J, et al. Long-term outcomes of thalidomide therapy for adults with refractory Crohn’s disease. Clin Gastroenterol Hepatol. 2016;14:966–972.
   PubMed Web of Science ®Google Scholar
• Ferrari L, Krane MK, Fichera A. Inflammatory bowel disease surgery in the biologic era. World J Gastrointest Surg. 2016;8:363–370.
   PubMed Web of Science ®Google Scholar
• Reimund JM, Wittersheim C, Dumont S, et al. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn’s disease. Gut. 1996;39:684–689.
   PubMed Web of Science ®Google Scholar
• Ungar B, Kopylov U. Advances in the development of new biologics in inflammatory bowel disease. Ann Gastroenterol. 2016;29:243–248.
   PubMed Web of Science ®Google Scholar
• Vermeire S, Loftus EV Jr, Colombel JF, et al. Long-term efficacy of vedolizumab for Crohn’s disease. J Crohns Colitis. 2016 Sep 28. Epub ahead of print.
   Web of Science ®Google Scholar
• Schwab N, Schneider-Hohendorf T, Melzer N, et al. Natalizumab-associated PML: challenges with incidence, resulting risk, and risk stratification. Neurology. 2017;88:1197–1205.
   PubMed Web of Science ®Google Scholar
• Hansen T, Targownik LE. Ustekinumab for the treatment of Crohn’s disease. Expert Rev Gastroenterol Hepatol. 2016;10:989–994.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Ghosh S, Panes J, et al. A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2014;12:1485–1493.
   PubMed Web of Science ®Google Scholar
• Vaughn BP, Vatanen T, Allegretti JR, et al. Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn’s disease. Inflamm Bowel Dis. 2016;22:2182–2190.
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Allez M, Clark MM, et al. Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial. Jama. 2015;314:2524–2534.
   PubMed Web of Science ®Google Scholar
• Pó C, Begun J, Keely S, et al. Towards an integrated understanding of the therapeutic utility of exclusive enteral nutrition in the treatment of Crohn’s disease. Food Funct. 2016;7:1741–1751.
   PubMed Web of Science ®Google Scholar
• Day AS, Lopez RN. Exclusive enteral nutrition in children with Crohn’s disease. World J Gastroenterol. 2015;21:6809–6816.
   PubMed Web of Science ®Google Scholar
• Triantafillidis JK, Papalois AE. The role of total parenteral nutrition in inflammatory bowel disease: current aspects. Scand J Gastroenterol. 2014;49:3–14.
   PubMed Web of Science ®Google Scholar
• Schwartz LSM, Schiano T, Chamberlain C, et al. Crohn’s disease-related short bowel syndrome: outcomes in intestinal rehabilitation and transplantation.” XII International Small Bowel Transplant Symposium, Washington, DC, 2011.
   Google Scholar
• Rieder F, Zimmermann EM, Remzi FH, et al. Crohn’s disease complicated by strictures: a systematic review. Gut. 2013;62:1072–1084.
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429.
   PubMed Web of Science ®Google Scholar
• Malgras B, Soyer P, Boudiaf M, et al. Accuracy of imaging for predicting operative approach in Crohn’s disease. Br J Surg. 2012;99:1011–1020.
   PubMed Web of Science ®Google Scholar
• Alves A, Panis Y, Bouhnik Y, et al. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum. 2007;50:331–336.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum. 2000;43:1141–1145.
   PubMed Web of Science ®Google Scholar
• Amiot A, Messing B, Corcos O, et al. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. Clin Nutr. 2013;32:368–374.
   PubMed Web of Science ®Google Scholar
• Van Koperen PJ, Safiruddin F, Bemelman WA, et al. Outcome of surgical treatment for fistula in ano in Crohn’s disease. Br J Surg. 2009;96:675–679.
   PubMed Web of Science ®Google Scholar
• Soltani A, Kaiser AM. Endorectal advancement flap for cryptoglandular or Crohn’s fistula-in-ano. Dis Colon Rectum. 2010;53:486–495.
   PubMed Web of Science ®Google Scholar
• Rojanasakul A. LIFT procedure: a simplified technique for fistula-in-ano. Tech Coloproctol. 2009;13:237–240.
   PubMed Web of Science ®Google Scholar
• Grimaud JC, Munoz-Bongrand N, Siproudhis L et al. Fibrin glue is effective healing perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2010;138:2275–2281.
   PubMed Web of Science ®Google Scholar
• Iesalnieks I, Kilger A, Glass H, et al. Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Colorectal Dis. 2008;23:1167–1174.
   PubMed Web of Science ®Google Scholar
• Copeland GP. The POSSUM system of surgical audit. Arch Surg. 2002;137:15–19.
   PubMedGoogle Scholar
• Lee JS, Kim HJ, Cho HM, et al. The importance of the Crohn’s disease activity index in surgery for small bowel Crohn’s disease. J Visc Surg. 2016;153:339–345.
   PubMed Web of Science ®Google Scholar
• De Angelis N, Carra MC, Borrelli O, et al. Short and long-term efficacy of endoscopic balloon dilatation in Crohn’s disease strictures. World J Gastroenterol. 2013;19:2660–2667.
   PubMed Web of Science ®Google Scholar
• Hagel AF, Hahn A, Dauth W, et al. Outcome and complications of endoscopic balloon dilatations in various types of ileocaecal and colonic stenosis in patients with Crohn’s disease. Surg Endosc. 2014;10:2966–2972.
   Web of Science ®Google Scholar
• Hassan C, Zullo A, De Francesco V, et al. Systematic review: endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther. 2007;26:1457–1464.
   PubMed Web of Science ®Google Scholar
• Thienpont C, D’Hoore A, Vermeire S, et al. Long-term outcome of endoscopic dilatation in patients with Crohn’s disease is not affected by disease activity or medical therapy. Gut. 2010;59:320–324.
   PubMed Web of Science ®Google Scholar
• East JE, Brooker JC, Rutter MD, et al. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn’s strictures. Clin Gastroenterol Hepatol. 2007;5:1065–1069.
   PubMed Web of Science ®Google Scholar
• Di Nardo G, Oliva S, Passariello M, et al. Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn’s disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc. 2010;72:1201–1208.
   PubMed Web of Science ®Google Scholar
• Atreja A, Aggarwal A, Dwivedi S, et al. Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn’s disease strictures. J Crohns Colitis. 2014;8:392–400.
   PubMed Web of Science ®Google Scholar
• Wibmer AG, Kroesen AJ, Gröne J, et al. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease – review of the literature. Int J Colorectal Dis. 2010;25:1149–1157.
   PubMed Web of Science ®Google Scholar
• Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis. 2010;4:28–62.
   PubMed Web of Science ®Google Scholar
• Geiger TM, Miedema BW, Tsereteli Z, et al. Stent placement for benign colonic stenosis: case report, review of the literature, and animal pilot data. Int J Colorectal Dis. 2008;23:1007–1012.
   PubMed Web of Science ®Google Scholar
• Thomas T, Abrams KR, Subramanian V, et al. Esophageal stents for benign refractory strictures: a meta-analysis. Endoscopy. 2011;43:386–393.
   PubMed Web of Science ®Google Scholar
• Attar A, Maunoury V, Vahedi K, et al. Safety and efficacy of extractible self-expandable metal stents in the treatment of Crohn’s disease intestinal strictures: a prospective pilot study. Inflamm Bowel Dis. 2012;18:1849–1854.
   PubMed Web of Science ®Google Scholar
• Branche J, Attar A, Vernier-Massouille G, et al. Extractible self-expandable metal stent in the treatment of Crohn’s disease anastomotic strictures. Endoscopy. 2012;44:E325–E326.
   PubMed Web of Science ®Google Scholar
• Hesham W, Kann BR. Strictureplasty. Clin Colon Rectal Surg. 2013;26:80–83.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: special situations. J Crohns Colitis. 2010;4:63–101.
   PubMed Web of Science ®Google Scholar
• Dietz DW, Laureti S, Strong SA, et al. Safety and long-term efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg. 2001;192:330–337.
   PubMed Web of Science ®Google Scholar
• Futami K, Arima S. Role of strictureplasty in surgical treatment of Crohn’s disease. J Gastroenterol. 2005;40:35–39.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2007;50:1968–1986.
   PubMed Web of Science ®Google Scholar
• Broering DC, Eisenberger CF, Koch A, et al. Strictureplasty for large bowel stenosis in Crohn’s disease: quality of life after surgical therapy. Int J Colorectal Dis. 2001;16:81–87.
   PubMed Web of Science ®Google Scholar
• Michelassi F, Taschieri A, Tonelli F, et al. An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn’s disease. Dis Colon Rectum. 2007;50:277–284.
   PubMed Web of Science ®Google Scholar
• Reese GE, Purkayastha S, Tilney HS, et al. Strictureplasty vs resection in small bowel Crohn’s disease: an evaluation of short-term outcomes and recurrence. Colorectal Dis. 2007;9:686–694.
   PubMed Web of Science ®Google Scholar
• Ambe R, Campbell L, Cagir B. A comprehensive review of strictureplasty techniques in Crohn’s disease: types, indications, comparisons, and safety. J Gastrointest Surg. 2012;16:209–217.
   PubMed Web of Science ®Google Scholar
• Yaffe BH, Korelitz BI. Prognosis for nonoperative management of small-bowel obstruction in Crohn’s disease. J Clin Gastroenterol. 1983;5:211–215.
   PubMed Web of Science ®Google Scholar
• Campbell L, Ambe R, Weaver J, et al. Comparison of conventional and nonconventional strictureplasties in Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum. 2012;55:714–726.
   PubMed Web of Science ®Google Scholar
• Tilney HS, Constantinides VA, Heriot AG, et al. Comparison of laparoscopic and open ileocecal resection for Crohn’s disease: a meta-analysis. Surg Endosc. 2006;20:1036–1044.
   PubMed Web of Science ®Google Scholar
• Maartense S, Dunker MS, Slors JFM, et al. Laparoscopic-assisted versus open ileocolic resection for Crohn’s disease: a randomized trial.”. Ann Surg. 2006;243:143–149.
   PubMed Web of Science ®Google Scholar
• Shaffer VO, Wexner SD. Surgical management of Crohn’s disease. Langenbecks Arch Surg. 2013;398:13–27.
   PubMed Web of Science ®Google Scholar
• Fazio VW, Marchetti F, Church M, et al. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg. 1996;224:563–571.
   PubMed Web of Science ®Google Scholar
• McLeod RS, Wolff BG, Ross S, et al. Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum. 2009;52:919–927.
   PubMed Web of Science ®Google Scholar
• Tonelli F, Fazi M, Di Martino C. Ileocecal strictureplasty for Crohn’s disease: long-term results and comparison with ileocecal resection. World J Surg. 2010;34:2860–2866.
   PubMed Web of Science ®Google Scholar
• Schlussel AT, Steele SR, Alavi K. Current challenges in the surgical management of Crohn’s disease, a systematic review. Am J Surg. 2016;212:345–351.
   PubMed Web of Science ®Google Scholar
• Uchino M, Ikeuchi H, Matsuoka H, et al. Long-term efficacy of strictureplasty for Crohn’s disease. Surg Today. 2010;40:949–953.
   PubMed Web of Science ®Google Scholar
• Simillis C, Purkayastha S, Yamamoto T, et al. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis Colon Rectum. 2007;50:1674–1687.
   PubMed Web of Science ®Google Scholar
• Scarpa M, Angriman I, Barollo M, et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn’s disease. Hepatogastroenterology. 2004;51:1053–1057.
   PubMedGoogle Scholar
• Nguyen DL, Nguyen ET. Bechtold ML. Outcomes of initial medical compared with surgical strategies in the management of intra-abdominal abscesses in patients with Crohn’s disease: a meta-analysis. Eur J Gastroenterol Hepatol. 2015;27:235–241.
   PubMed Web of Science ®Google Scholar
• De Groof EJ, Carbonnel F, Buskens CJ, et al. Abdominal abscess in Crohn’s disease: multidisciplinary management. Dig Dis. 2014;32:103–109.
   PubMed Web of Science ®Google Scholar
• Gutierrez A, Lee H, Sands BE. Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn’s disease. Am J Gastroenterol. 2006;101:2283–2289.
   PubMed Web of Science ®Google Scholar
• Frolkis AD, Lipton DS, Fiest KM, et al. Cumulative incidence of second intestinal resection in Crohn’s disease: a systematic review and meta-analysis of population-based studies. Am J Gastroenterol. 2014;109:1739–1748.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Sasaki I, Fukushima K, et al. Long-term incidence and characteristics of intestinal failure in Crohn’s disease: a multicenter study. J Gastroenterol. 2014;49:231–238.
   PubMed Web of Science ®Google Scholar
• Limketkai BN, Orandi BJ, Luo X, et al. Mortality and rates of graft rejection or failure following intestinal transplantation in patients with vs without Crohn’s disease. Clin Gastroenterol Hepato. 2016;14:1574–1581.
   PubMed Web of Science ®Google Scholar
• Harpaz N, Schiano T, Ruf AE, et al. Early and frequent histological recurrence of Crohn’s disease in small intestinal allografts. Transplantation. 2005;80:1667–1670.
   PubMed Web of Science ®Google Scholar
• Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestine Transplant Registry report: global activities and trends. Am J Transplant. 2015;15:210–219.
   PubMed Web of Science ®Google Scholar
• Desai CS, Gruessner AC, Khan KM, et al. Isolated intestinal transplants vs liver-intestinal transplants in adult patients in the United States: 22 yr of the OPTN data. Clin Transplant. 2012;26:622–628.
   PubMed Web of Science ®Google Scholar
• Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet. 2001;357:1925–1928.
   PubMed Web of Science ®Google Scholar
• Fishbein T, Novitsky G, Mishra L, et al. NOD-2 expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut. 2008;57:323–330.
   PubMed Web of Science ®Google Scholar
• Janse M, Weersma RK, Sudan DL, et al. Association of Crohn’s disease-associated NOD2 variants with intestinal failure requiring small bowel transplantation and clinical outcomes. Gut. 2011;60:877–878.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, et al. A frameshit mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.
   PubMed Web of Science ®Google Scholar
• Pascher A, Klupp J, Kohler S, et al. Transplantation of an eight organ multivisceral graft in a patient with frozen abdomen after complicated Crohn’s disease. World J Gastroenterol. 2006;12:4431–4434.
   PubMed Web of Science ®Google Scholar
• Eid KR, Costa G, Bond GJ, et al. An innovative sphincter preserving pull-trough technique with en-block colon and small bowel transplantation. Am J Transplant. 2010;10:1940–1946.
   PubMed Web of Science ®Google Scholar
• Sustento-Reodica N, Ruiz P, Rogers A, et al. Recurrent Crohn’s disease in transplanted bowel. Lancet. 1997;349:688–691.
   PubMed Web of Science ®Google Scholar
• Matsumoto CS, Zasloff MA, Fishbein TM. Chronic mucosal inflammation/inflammatory bowel disease-like inflammation after intestinal transplantation: where are we now? Curr Opin Organ Transplant. 2014;19:276–280.
   PubMed Web of Science ®Google Scholar
• Mannu GS, Vaidya A. Graft versus host disease following small bowel and abdominal wall transplantation. BMJ Case Rep. 2014;pii: bcr2014205983. DOI:10.1136/bcr-2014-205983
   Google Scholar
• Kaila B, Grant D, Pettigrew N, et al. Crohn’s disease recurrence in a small bowel transplant. Am J Gastroenterol. 2004;99:158–162.
   PubMed Web of Science ®Google Scholar
• Nyabanga C, Kochhar G, Costa G, et al. Management of Crohn's Disease in the New Era of Gut Rehabilitation and Intestinal Transplantation. Inflamm Bowel Dis. 2016;22:1763–1776.
   PubMed Web of Science ®Google Scholar
• Fishbein TM. Intestinal transplantation. N Engl J Med. 2009;361:998–1008.
   PubMed Web of Science ®Google Scholar
• Gerlach UA, Koch M, Muller HP, et al. Tumor necrosis factor alpha inhibitors as immunomodulatory antirejection agents after intestinal transplantation. Am J Transplant. 2011;11:1041–1050.
   PubMed Web of Science ®Google Scholar
• De Greef E, Avitzur Y, Grant D, et al. Infliximab as salvage therapy in pediatric intestinal transplant with steroid and thymoglobulin resistant late acute rejection. J Pediatr Gastroenterol Nutr. 2012;54:565–567.
   PubMed Web of Science ®Google Scholar
• Gerlach UA, Vrakas G, Reddy S, et al. Chronic intestinal failure after Crohn disease. When to perform transplantation. JAMA Surg. 2014;149:1060–1066.
   PubMed Web of Science ®Google Scholar
• Gondolesi GE, Almau HM. Intestinal transplantation outcomes. Mt Sinai J Med. 2012;79:246–255.
   PubMedGoogle Scholar
• Nyabanga C, Kochhar G, Costa G, et al. Management of Crohn’s disease in the new era of gut rehabilitation and intestinal transplantation. Inflamm Bowel Dis. 2016;22:1763–1776.
   PubMed Web of Science ®Google Scholar
• Buchner AM, Wallace MB. Endomicroscopy and molecular tools to evaluate inflammatory bowel disease.” Gastrointest Endosc Clin N Am. 2016;26:657–668.
   PubMedGoogle Scholar
• Millis JM. Crohn disease and intestinal transplantation: benefit balance. JAMA Surg. 2014;149:1067.
   PubMed Web of Science ®Google Scholar
• Drastich P, Oliverius M. Crohn’s disease and intestinal transplantation. Dig Dis. 2017;35:127–133.
   PubMed Web of Science ®Google Scholar
• Rao B, Jafri SM, Kazimi M, et al. A case report of acute cellular rejection following intestinal transplantation managed with adalimumab. Transplant Proc. 2016;48:536–538.
   PubMed Web of Science ®Google Scholar
• Rutter CS, Amin I, Russell NK, et al. Adult intestinal and multivisceral transplantation: experience from a single center in the United Kingdom. Transplant Proc. 2016;48:468–472.
   PubMed Web of Science ®Google Scholar
• Haveman JW, Tempelman TM, Hofker HS, et al. First combined intestinal and abdominal wall transplantation in the Netherlands. Ned Tijdschr Geneeskd. 2016;160:A9788. article in Dutch.
   PubMedGoogle Scholar
• Bharadwaj S, Tandon P, Meka K, et al. Intestinal failure: adaptation, rehabilitation, and transplantation. J Clin Gastroenterol. 2016;50:366–372.
   PubMed Web of Science ®Google Scholar
• Ceulemans LJ, Monbaliu D, De Roover A, et al. Belgian multicenter experience with intestinal transplantation. Transpl Int. 2015;28:1362–1370.
   PubMed Web of Science ®Google Scholar
• Nassar A, Hashimoto K, Shay-Downer C, et al. Sequential split liver followed by isolated intestinal transplant: the “liver-first” approach: report of a case.” Transplantation. 2014;97:e17–19.
   Google Scholar
• Primeggia J, Matsumoto CS, Fishbein TM, et al. Infection among adult small bowel and multivisceral transplant recipients in the 30-day postoperative period. Transpl Infect Dis. 2013;15:441–448.
   PubMed Web of Science ®Google Scholar
• Subramanian S. Small bowel transplantation for the treatment of Crohn’s disease. Gastroenterol Hepatol (N Y). 2012;8:545–547.
   PubMedGoogle Scholar
• Desai CS, Khan K, Gruessner A, et al. Outcome of intestinal transplants for patients with Crohn’s disease. Transplant Proc. 2013;45:3356–3360.
   PubMed Web of Science ®Google Scholar
• Lough D, Abdo J, Guerra-Castro JF, et al. Abnormal CX3CR1⁺ lamina propria myeloid cells from intestinal transplant recipients with NOD2 mutations. Am J Transplant. 2012;12:992–1003.
   PubMed Web of Science ®Google Scholar
• Ningappa M, Higgs BW, Weeks DE, et al. NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome. Am J Gastroenterol. 2011;106:157–165.
   PubMed Web of Science ®Google Scholar
• Ruiz P, Carreno M, Weppler D, et al. Immediate antibody-mediated (hyperacute) rejection in small-bowel transplantation and relationship to cross-match status and donor-specific C4d-binding antibodies: case report. Transplant Proc. 2010;42:95–99.
   PubMed Web of Science ®Google Scholar
• Akhavan A, Jackman SV, Costa G, et al. Urogenital disorders associated with gut failure and intestinal transplantation. J Urol. 2007;178:2067–2072.
   PubMed Web of Science ®Google Scholar
• Ueno T, Kato T, Gaynor J, et al. Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. Transplant Proc. 2006;38:1762–1764.
   PubMed Web of Science ®Google Scholar
• Glas J, Folwaczny M, Folwaczny C, et al. Crohn’s disease recurrence in small bowel transplant. Am J Gastroenterol. 2004;99:2067.
   PubMed Web of Science ®Google Scholar
• Mims TT, Fishbein TM, Feierman DE. Management of a small bowel transplant with complicated central venous access in a patient with asymptomatic superior and inferior vena cava obstruction. Transplant Proc. 2004;36:388–391.
   PubMed Web of Science ®Google Scholar
• Nishida S, Levi D, Kato T, et al. Ninety-five cases of intestinal transplantation at the University of Miami. J Gastrointest Surg. 2002;6:233–239.
   PubMed Web of Science ®Google Scholar
• DiMartini A, Fitzgerald MG, Magill J, et al. Psychiatric evaluations of small intestine transplantation patients. Gen Hosp Psychiatry. 1996;18:25S–29S.
   PubMed Web of Science ®Google Scholar
• Friend PJ, Jamieson NV, Klinck J, et al. Early experience with clinical intestinal transplantation. Transplant Proc. 1996;28:2744–2745.
   PubMed Web of Science ®Google Scholar